University Hospital, Strasbourg, France
Clinical trials sponsored by University Hospital, Strasbourg, France, explained in plain language.
-
Could a diabetes pill save lives in septic shock?
Disease control Not yet recruitingThis study tests whether dapagliflozin, a drug used for diabetes, can help people with septic shock—a severe infection that causes organ failure. The drug aims to protect blood vessels and reduce inflammation. About 568 ICU patients will receive either dapagliflozin or a placebo,…
Phase: PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 16, 2026 21:34 UTC
-
Personalized approach may let some schizophrenia patients reduce meds
Disease control Not yet recruitingThis study tests whether stable schizophrenia patients can safely reduce their antipsychotic medication without losing function. 288 adults aged 18-60 will be grouped by their specific psychosis type and randomly assigned to either dose reduction or standard maintenance. The goal…
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
Could a simpler surgery be just as effective for aggressive uterine cancer?
Disease control Not yet recruitingThis study compares two surgical approaches for women with early-stage, high-risk endometrial cancer that has a p53 gene mutation. One group will receive the standard surgery that removes many lymph nodes, while the other group will have a less invasive sentinel lymph node biopsy…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Could a lung drug fix deadly clotting in sepsis?
Disease control Not yet recruitingThis study tests a drug called sivelestat in 120 adults with septic shock and blood clotting problems. The drug aims to restore the body's ability to break down small clots, which may improve survival. Participants will receive either the drug or a placebo for 24 hours, and docto…
Phase: PHASE2 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
AI-Powered blood test could spot deadly clotting complication hours earlier
Diagnosis Not yet recruitingThis study aims to validate a new blood test that uses artificial intelligence to quickly diagnose a severe clotting disorder (DIC) in patients with septic shock. DIC is a life-threatening complication that is hard to detect early with current methods. Researchers will test the n…
Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 15, 2026 19:06 UTC
-
Bad breath diagnosis goes remote: bagged breath test studied
Diagnosis Not yet recruitingThis study tests whether breath samples collected in special bags remain accurate for diagnosing halitosis (bad breath) after 7 days. About 100 adults with gum disease will provide breath samples, which are analyzed immediately and again a week later. If the gas levels stay stabl…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 15, 2026 18:56 UTC
-
New spinal fluid test aims to end misdiagnosis of common dementia
Diagnosis Not yet recruitingThis study aims to see if measuring a specific form of the protein alpha-synuclein in spinal fluid can reliably distinguish dementia with Lewy bodies (DLB) from Alzheimer's disease. About 286 adults aged 50 and older with signs of either condition will have a lumbar puncture to c…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Diagnosis
Last updated Jun 12, 2026 12:11 UTC
-
Tailored therapy could ease psychosis symptoms
Symptom relief Not yet recruitingThis study compares a standard mental training program (Metacognitive Training) with a personalized version for 51 adults with schizophrenia spectrum disorder. The personalized program uses machine learning to target each person's specific thinking patterns. The goal is to see wh…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 16, 2026 21:35 UTC
-
Light beams to the brain: a new hope for lewy body disease?
Symptom relief Not yet recruitingThis study tests a new, non-invasive light therapy (photobiomodulation) for people with Lewy body disease, a common type of dementia. The treatment uses red and infrared light to stimulate brain cells, aiming to improve thinking, movement, and quality of life. Forty adults aged 5…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 16, 2026 12:48 UTC
-
Virtual reality offers new hope for comfort in final months
Symptom relief Not yet recruitingThis study explores whether using interactive virtual reality (VR) can help reduce pain, anxiety, and fatigue in people receiving palliative care. Twenty hospitalized adults with a life expectancy of at least one month will try daily VR sessions where they can interact with a cal…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
Could melatonin be the key to better sleep for kids with PTSD?
Symptom relief Not yet recruitingThis study tests a special type of melatonin (a natural sleep hormone) in children and teens aged 2 to 17 with PTSD who have serious sleep problems like trouble falling asleep, waking up often, or nightmares. The goal is to see if it helps them sleep longer and better, and if tha…
Phase: PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
VR headsets tested as Drug-Free relief for seriously ill patients
Symptom relief Not yet recruitingThis study tests whether using a virtual reality (VR) headset for 10 minutes a day can help reduce pain, anxiety, and fatigue in people receiving palliative care. About 40 adults with complex needs will be randomly assigned to either a fully immersive VR experience or a less imme…
Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
New under-the-tongue pain drug may speed up post-surgery recovery
Symptom relief Not yet recruitingThis study compares a new under-the-tongue painkiller (sublingual sufentanil) to standard oral morphine for managing pain after surgery. Researchers want to see if the new drug helps patients recover their health faster and better. About 1,150 adults having surgery will take part…
Phase: PHASE4 • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC
-
Personalized recovery plans tested for complex surgery patients
Symptom relief Not yet recruitingThis study tests whether a personalized follow-up program, based on patients' own reports of how they feel, can improve recovery after complex surgery. About 276 adults with complex care needs will be randomly assigned to either receive this extra support or standard care. The go…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 12, 2026 12:07 UTC
-
Hypnosis and smell therapy join forces to fight alcohol withdrawal anxiety
Symptom relief Not yet recruitingThis study tests a new way to help people going through alcohol withdrawal feel less anxious. It combines hypnosis with aromatherapy, using a calming scent to trigger the relaxation learned during hypnosis. About 80 adults in a hospital addiction unit will either get this combine…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 12, 2026 12:05 UTC
-
New study tests online vs In-Person therapy for addiction and emotional control
Symptom relief Not yet recruitingThis study compares dialectical behavior therapy (DBT) — given either in-person or online via videos — to usual treatment for adults with addiction and emotional regulation difficulties. The goal is to see if DBT improves emotional control and reduces impulsive behavior. About 12…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 10, 2026 13:29 UTC
-
Could a collapsed lung be treated at home? new study investigates
Symptom relief Not yet recruitingThis study looks at whether treating a first-time collapsed lung (pneumothorax) at home, instead of in the hospital, can improve quality of life. About 386 adults aged 18 to 50 will be randomly assigned to either outpatient care or standard inpatient care. The main goal is to see…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 10, 2026 13:27 UTC
-
VR goggles replace sedation for wisdom teeth?
Symptom relief Not yet recruitingThis study tests whether using virtual reality (VR) with calming scripts can lower anxiety and pain during wisdom tooth extraction. Sixty adults aged 18 to 65 who need at least two lower wisdom teeth removed will either get standard care or VR distraction. The goal is to see if V…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 08, 2026 13:18 UTC
-
Eye twitch could be early MS warning sign, new study hopes to prove
Knowledge-focused Not yet recruitingThis study looks at 200 people who have internuclear ophthalmoplegia, an eye movement problem often linked to multiple sclerosis (MS). Researchers want to see how many of these people later develop MS and find clues that might help doctors diagnose MS sooner. By reviewing past me…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 16, 2026 21:35 UTC
-
New DNA reader aims to solve mystery of childhood epilepsy cases
Knowledge-focused Not yet recruitingThis study tests a new DNA technology called long-read genome sequencing in 20 children with severe epilepsy whose standard genetic tests came back normal. The goal is to find hidden genetic causes that standard tests miss, which could lead to better treatments and genetic counse…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 16, 2026 21:33 UTC
-
Could a diabetes drug target help leg artery disease? new study investigates
Knowledge-focused Not yet recruitingThis observational study will examine whether a protein called the GLP-1 receptor, found on certain blood cells, is linked to the severity of peripheral artery disease (PAD). Researchers will compare 50 adults with mild versus severe PAD by analyzing a single extra blood sample t…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC
-
New study probes emotional toll of SMA screening on parents
Knowledge-focused Not yet recruitingThis study looks at how parents react emotionally and psychologically when their newborn tests positive for spinal muscular atrophy (SMA) through routine screening. Researchers will interview about 36 parents in two French regions and ask them to complete questionnaires about anx…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:06 UTC
-
New study tracks emotional shifts in autistic women across their cycle
Knowledge-focused Not yet recruitingThis study looks at how emotions change throughout the menstrual cycle in autistic women. Researchers will compare them to women with borderline personality disorder, premenstrual dysphoric disorder, and women without any diagnosed condition. The goal is to better understand emot…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC
-
Glow of white blood cells may predict sepsis danger in ER
Knowledge-focused Not yet recruitingThis study looks at whether measuring the fluorescence of certain white blood cells (neutrophils) can help doctors quickly identify sepsis patients at risk of severe complications like organ failure or septic shock. Researchers will analyze blood samples from 492 adults in the em…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC
-
Blood test study aims to predict bleeding risks in cancer patients
Knowledge-focused Not yet recruitingThis study looks at how blood clots break down in cancer patients who also have bleeding disorders. Researchers will measure a protein called plasminogen in 150 adults with blood cancers, solid tumors, or septic shock. The goal is to gather data for a larger study that could help…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC
-
Scientists hunt for rogue immune cells in autoimmune diseases
Knowledge-focused Not yet recruitingThis study aims to better understand why some people's immune cells attack their own body, causing autoimmune diseases like lupus and scleroderma. Researchers will analyze blood samples from 200 adults with these conditions to identify and measure specific harmful immune cells. T…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:57 UTC
-
New study tests Dye-Free 3D scans for lung cancer surgery planning
Knowledge-focused Not yet recruitingThis study will check if 3D models made from CT scans without contrast dye are as accurate as regular 2D CT scans with dye for planning minimally invasive lung cancer surgery. About 50 adults with early-stage lung cancer will take part. The goal is to see if the 3D method can rel…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
Brain zapping study aims to unlock Cerebellum's secrets
Knowledge-focused Not yet recruitingThis study looks at how a non-invasive brain stimulation technique called rTMS affects two different areas of the cerebellum—one tied to movement and one tied to thinking. Forty healthy adults will receive either stimulating, inhibiting, or fake stimulation, and researchers will …
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:05 UTC
-
Can less dye give clear brain images?
Knowledge-focused Not yet recruitingThis study tests whether using less contrast dye during brain scans for unruptured aneurysms can still produce clear images. About 244 adults will be randomly assigned to receive either the standard dye amount or a reduced amount. The goal is to find a safer, more comfortable way…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:12 UTC
-
Blood marker may predict deadly bleeding in Life-Support patients
Knowledge-focused Not yet recruitingThis study will follow 100 intensive care patients on ECMO (a heart-lung machine) to see if changes in a blood marker called D-dimer can predict serious bleeding within 24 hours. Bleeding is a major risk for these patients, and finding a way to forecast it could help doctors act …
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 08, 2026 13:11 UTC
-
New study aims to unravel Fatigue's role in CMT1A mobility
Knowledge-focused Not yet recruitingThis study looks at how fatigue affects walking and balance in people with Charcot-Marie-Tooth type 1A (CMT1A), a common inherited nerve disorder. Researchers will compare 44 participants (22 with CMT1A and 22 healthy volunteers) using muscle tests, brain stimulation, and movemen…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:06 UTC
-
MS mystery: do some relapses hide from MRI scans?
Knowledge-focused Not yet recruitingThis study looks at whether people with relapsing-remitting multiple sclerosis (RRMS) can have a relapse—new or worsening symptoms—without any visible inflammation on an MRI scan. Researchers will follow 136 adults who are having a suspected relapse, performing early brain and sp…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 02, 2026 11:57 UTC